Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

Recent & Breaking News (TSX:BCT)

BriaCell to Partner With Top U.S. Medical Institution Washington University to Produce Its BriaVax(TM) Cancer Vaccine

Marketwired May 27, 2015

BriaCell Therapeutics Successfully Completes Testing Requested by FDA

Marketwired May 19, 2015

BriaCell Therapeutics Submits Phase-I/II Protocol to the US FDA

Marketwired March 10, 2015

BriaCell Therapeutics to Present at the 2015 BIO CEO and Investor Conference

Marketwired February 4, 2015

BriaCell Therapeutics Announces Top US Oncologist to Lead Its Clinical Trial

Marketwired January 7, 2015

BriaCell Therapeutics Announces Closing of Go-Public Onto Toronto Stock Exchange Venture, Closing of Concurrent Financing With Agents Sunel Securities and M Partners, Closing of Hospital Partnership and Royalty Relinquishment Corporate Update

GlobeNewswire December 3, 2014

IIROC Trade Resumption - BriaCell Therapeutics Corp.

Newsfile December 2, 2014

Ansell Capital Corp. Announces Proposed Reverse Takeover Transaction With BriaCell Therapeutics Corp.

Marketwired April 17, 2014

Ansell Capital Corp. Announces Proposed Reverse Takeover Transaction With BriaCell Therapeutics Corp.

Marketwired April 17, 2014

Medical marijuana update: Tweed hits resistance at an ironic $4.20

Chris Parry April 8, 2014

IIROC Trading Halt - ACP

Canada NewsWire April 8, 2014

IIROC Trade Halt - Ansell Capital Corp.

Newsfile April 8, 2014

Medical marijuana update: The ghostly chill of bubble paranoia

Chris Parry March 26, 2014

Medical marijuana update: Next Gen (C.N) flies 25% on ‘VC of the industry’ talk

Chris Parry March 25, 2014

Medical marijuana stocks drop as deadline stayed

Chris Parry March 24, 2014

Medical Marijuana Update: V.THC makes a run as Next Gen launches plan

Chris Parry March 20, 2014

Medical marijuana update: Big money moves to Next Gen

Chris Parry March 19, 2014

Marijuana stocks slip as Abbatis, Enertopia, Next Gen streak

Chris Parry March 18, 2014

Medical marijuana update: Rumors, runs and rags-to-riches

Chris Parry March 17, 2014

Ansell Capital Corporate Update

Marketwired March 13, 2014